Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention
Sang Beom Lee(Medical College of Wisconsin), Yian Wang(Hunan Normal University), Jeffrey E. Green(Northwestern University), Shizuko Sei(National Cancer Institute), Donghai Xiong(Medical College of Wisconsin), Bryon D. Johnson(Medical College of Wisconsin), Katie Palen(Medical College of Wisconsin), Robert H. Shoemaker(Frederick National Laboratory for Cancer Research), Pan Jing(Houston Methodist), Ming You(Medical College of Wisconsin), Romaine I. Fernando(National Cancer Institute), Ronald A. Lubet(National Cancer Institute)
Cited by 22
Related Papers
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
|Cell|2006|1.4k
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
|Genome biology|2007|1.3k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence
|Nature Communications|2018|418
A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response
|Nature Communications|2020|246